These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 1848475

  • 1. Soluble interleukin-2 receptors in patients with nasopharyngeal carcinoma.
    Lai KN, Ho S, Leung JC, Tsao SY.
    Cancer; 1991 Apr 15; 67(8):2180-5. PubMed ID: 1848475
    [Abstract] [Full Text] [Related]

  • 2. Soluble interleukin-2 receptor as a clinical parameter for nasopharyngeal carcinoma.
    Hsu MM, Chen YJ, Chang YL, Ko JY, Sheen TS.
    Asian Pac J Allergy Immunol; 1995 Jun 15; 13(1):1-4. PubMed ID: 7488337
    [Abstract] [Full Text] [Related]

  • 3. The significance of soluble interleukin-2 receptor in monitoring disease relapse in patients with nasopharyngeal cancer.
    Wu LJ, Chen KY, Chi KH, Chen SY, Liang MJ, Shiau CY, Wang LW, Liu YM, Chow KC, Yen SH.
    Jpn J Clin Oncol; 1998 Dec 15; 28(12):729-32. PubMed ID: 9879289
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical significance of measuring levels of tumor necrosis factor-alpha and soluble interleukin-2 receptor in nasopharyngeal carcinoma.
    Hsiao SH, Lee MS, Lin HY, Su YC, Ho HC, Hwang JH, Lee CC, Hung SK.
    Acta Otolaryngol; 2009 Dec 15; 129(12):1519-23. PubMed ID: 19922107
    [Abstract] [Full Text] [Related]

  • 6. Expression of EBV antibody EA-IgA, Rta-IgG and VCA-IgA and SA in serum and the implication of combined assay in nasopharyngeal carcinoma diagnosis.
    Xia C, Zhu K, Zheng G.
    Int J Clin Exp Pathol; 2015 Dec 15; 8(12):16104-10. PubMed ID: 26884888
    [Abstract] [Full Text] [Related]

  • 7. Correlation Analysis of Nasopharyngeal Carcinoma TNM Staging with Serum EA IgA and VCA IgA in EBV and VEGF-C and -D.
    Sun R, Wang X, Li X.
    Med Sci Monit; 2015 Jul 20; 21():2105-9. PubMed ID: 26191775
    [Abstract] [Full Text] [Related]

  • 8. [The level of soluble interleukin 2 receptor in esophageal carcinoma patients before and after radiotherapy].
    Liu X, An H, Jiang Y.
    Zhonghua Zhong Liu Za Zhi; 1995 Mar 20; 17(2):97-9. PubMed ID: 7656815
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT, Yeh CY.
    Radiat Med; 1998 Mar 20; 16(2):113-7. PubMed ID: 9650898
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of Epstein-Barr virus antigen-based immunoassays for serological diagnosis of nasopharyngeal carcinoma.
    Tang JW, Rohwäder E, Chu IM, Tsang RK, Steinhagen K, Yeung AC, To KF, Chan PK.
    J Clin Virol; 2007 Dec 20; 40(4):284-8. PubMed ID: 17977062
    [Abstract] [Full Text] [Related]

  • 11. Rta-IgG as a biomarker for diagnosis and post treatment prognostic of nasopharyngeal carcinoma.
    Xu XF, Lu RQ, Xiao R, Zhou L, Zhao XM, Hu XC, Gao X, Guo L.
    Cancer Biomark; 2016 Dec 20; 16(3):467-76. PubMed ID: 27062704
    [Abstract] [Full Text] [Related]

  • 12. [Relationship between clinical stages of nasopharyngeal carcinoma and Epstein-Barr virus antibodies Rta/IgG, EBNA1/IgA, VCA/IgA and EA/IgA].
    Cai YL, Zheng YM, Cheng JR, Wang W, Zhang YN, Wang WH, Wu YS, Zhong WM, Li J, Mo YK.
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar 20; 30(3):509-11. PubMed ID: 20335122
    [Abstract] [Full Text] [Related]

  • 13. [Combined detection of Epstein-Barr virus antibodies for serodiagnosis of nasopharyngeal carcinoma].
    Cai YL, Zheng YM, Wang W, Wei Y, Shen XX, Cheng JR, Wu YS, Gao JQ, Zhong WM, Li J.
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Dec 20; 30(12):2746-8. PubMed ID: 21177196
    [Abstract] [Full Text] [Related]

  • 14. Significance of plasma IgA and IgG antibodies to Epstein-Barr virus early and viral capsid antigens in Thai nasopharyngeal carcinoma.
    Tiwawech D, Srivatanakul P, Karaluk A, Ishida T.
    Asian Pac J Cancer Prev; 2003 Dec 20; 4(2):113-8. PubMed ID: 12875623
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic significance of combined detection of Epstein-Barr virus antibodies, VCA/IgA, EA/IgA, Rta/IgG and EBNA1/IgA for nasopharyngeal carcinoma.
    Cai YL, Li J, Lu AY, Zheng YM, Zhong WM, Wang W, Gao JQ, Zeng H, Cheng JR, Tang MZ.
    Asian Pac J Cancer Prev; 2014 Dec 20; 15(5):2001-6. PubMed ID: 24716925
    [Abstract] [Full Text] [Related]

  • 16. [Prognostic significance of serum anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma].
    Cai YL, Li J, Lu AY, Zhong WM, Zheng YM, Gao JQ, Zeng H, Chen WS, Liang W, Tang MZ.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Apr 20; 27(2):119-22. PubMed ID: 24044217
    [Abstract] [Full Text] [Related]

  • 17. [Assessment of detection assays of Epstein-Barr viral Rta-IgG, VCA-IgA, EA-IgA and Epstein-Barr viral DNA at different clinical stages in the diagnosis of nasopharyngeal carcinoma].
    Luo YL, Chen H, Peng SG, Lin JH, Huang PY.
    Zhonghua Yi Xue Za Zhi; 2013 Nov 26; 93(44):3516-9. PubMed ID: 24521892
    [Abstract] [Full Text] [Related]

  • 18. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma.
    Chan KH, Gu YL, Ng F, Ng PS, Seto WH, Sham JS, Chua D, Wei W, Chen YL, Luk W, Zong YS, Ng MH.
    Int J Cancer; 2003 Jul 10; 105(5):706-9. PubMed ID: 12740922
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of a semi-quantitative ELISA for IgA antibody against Epstein-Barr virus capsid antigen in the serological diagnosis of nasopharyngeal carcinoma.
    Chen H, Chi P, Wang W, Li L, Luo Y, Fu J, Zhang L, Liu W.
    Int J Infect Dis; 2014 Aug 10; 25():110-5. PubMed ID: 24878579
    [Abstract] [Full Text] [Related]

  • 20. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W, Chyczewska E, Kovalchuk O, Tałałaj J, Izycki T, Panek B.
    Rocz Akad Med Bialymst; 2004 Aug 10; 49():246-51. PubMed ID: 15631351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.